$NWBO
NORTHWEST BIOTHERAPEUTICS INC

2020 Q2 Form 10-Q Financial Statement

#000110465920092797 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $2.000K $581.0K $339.0K
YoY Change -99.66% 108.99% 156.82%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.318M $3.927M $5.101M
YoY Change 9.96% -74.42% 20.88%
% of Gross Profit
Research & Development $3.220M $3.291M $3.004M
YoY Change -2.16% -37.69% -36.53%
% of Gross Profit
Depreciation & Amortization $2.000K $6.000K $2.000K
YoY Change -66.67% -98.32% -99.45%
% of Gross Profit
Operating Expenses $3.220M $3.291M $3.004M
YoY Change -2.16% -37.69% -36.53%
Operating Profit -$7.536M -$6.637M -$7.766M
YoY Change 13.55% -67.39% -11.91%
Interest Expense $1.059M $787.0K $756.0K
YoY Change 34.56% -76.17% -77.26%
% of Operating Profit
Other Income/Expense, Net -$50.52M $6.856M -$13.18M
YoY Change -836.81% 3.54%
Pretax Income -$58.05M $219.0K -$20.95M
YoY Change -26607.76% -101.03% -2.8%
Income Tax
% Of Pretax Income
Net Earnings -$58.05M $219.0K -$20.95M
YoY Change -26607.76% -101.03% -2.78%
Net Earnings / Revenue -2902600.0% 37.69% -6178.76%
Basic Earnings Per Share -$0.08 $0.00
Diluted Earnings Per Share -$0.08 $0.00 -$39.59K
COMMON SHARES
Basic Shares Outstanding 697.6K 550.2K
Diluted Shares Outstanding 697.6K 597.4K

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.955M $6.676M $16.29M
YoY Change -10.8% 317.25% 8044.0%
Cash & Equivalents $5.955M $6.676M $1.970M
Short-Term Investments
Other Short-Term Assets $2.262M $2.230M $2.293M
YoY Change 1.43% 165.48% 146.56%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.217M $8.906M $18.58M
YoY Change -7.74% 265.75% 1544.34%
LONG-TERM ASSETS
Property, Plant & Equipment $157.0K $5.023M $277.0K
YoY Change -96.87% -89.08% -99.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $755.0K $775.0K $748.0K
YoY Change -2.58% 1170.49% 835.0%
Total Long-Term Assets $6.689M $5.798M $5.889M
YoY Change 15.37% -87.41% -87.9%
TOTAL ASSETS
Total Short-Term Assets $8.217M $8.906M $18.58M
Total Long-Term Assets $6.689M $5.798M $5.889M
Total Assets $14.91M $14.70M $24.47M
YoY Change 1.37% -69.67% -50.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.190M $6.435M $18.05M
YoY Change 27.27% -68.99% -11.02%
Accrued Expenses $311.0K $280.0K $270.0K
YoY Change 11.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $8.599M $0.00
YoY Change -100.0%
Long-Term Debt Due $12.88M $14.05M
YoY Change -31.08%
Total Short-Term Liabilities $88.57M $55.46M $74.22M
YoY Change 59.69% -43.72% -28.42%
LONG-TERM LIABILITIES
Long-Term Debt $3.173M $7.557M $4.001M
YoY Change -58.01% -44.92% -56.13%
Other Long-Term Liabilities $4.480M $4.690M $4.749M
YoY Change -4.48%
Total Long-Term Liabilities $7.653M $12.25M $8.750M
YoY Change -37.51% -10.74% -4.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $88.57M $55.46M $74.22M
Total Long-Term Liabilities $7.653M $12.25M $8.750M
Total Liabilities $96.22M $67.71M $82.97M
YoY Change 42.11% -39.69% -26.45%
SHAREHOLDERS EQUITY
Retained Earnings -$895.1M -$840.6M
YoY Change
Common Stock $812.2M $781.0M
YoY Change 6.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$83.01M -$54.24M -$58.50M
YoY Change
Total Liabilities & Shareholders Equity $14.91M $14.70M $24.47M
YoY Change 1.37% -69.67% -50.84%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$58.05M $219.0K -$20.95M
YoY Change -26607.76% -101.03% -2.78%
Depreciation, Depletion And Amortization $2.000K $6.000K $2.000K
YoY Change -66.67% -98.32% -99.45%
Cash From Operating Activities -$6.329M -$9.678M -$9.751M
YoY Change -34.6% -16.35% 103.7%
INVESTING ACTIVITIES
Capital Expenditures -$1.244M -$61.00K -$164.0K
YoY Change 1939.34%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.244M -$61.00K -$164.0K
YoY Change 1939.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.17M 29.00K 3.939M
YoY Change 45324.14% -99.71% -41.75%
NET CHANGE
Cash From Operating Activities -6.329M -9.678M -9.751M
Cash From Investing Activities -1.244M -61.00K -164.0K
Cash From Financing Activities 13.17M 29.00K 3.939M
Net Change In Cash 5.600M -9.710M -5.976M
YoY Change -157.67% 471.18% -402.58%
FREE CASH FLOW
Cash From Operating Activities -$6.329M -$9.678M -$9.751M
Capital Expenditures -$1.244M -$61.00K -$164.0K
Free Cash Flow -$5.085M -$9.617M -$9.587M
YoY Change -47.12% -16.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
722200000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
614300000
dei Entity Registrant Name
EntityRegistrantName
NORTHWEST BIOTHERAPEUTICS INC
dei Entity Central Index Key
EntityCentralIndexKey
0001072379
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q2 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
CY2020Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P2Y6M
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35737
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3306718
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 Montgomery Lane, Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
dei Entity Address Country
EntityAddressCountry
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
497-9024
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12g Title
Security12gTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
NWBO
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
731499352
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5955000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
372000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2262000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2828000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
8217000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
3200000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
157000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
281000
CY2020Q2 nwbo Constructions In Progress Net
ConstructionsInProgressNet
1541000
CY2019Q4 nwbo Constructions In Progress Net
ConstructionsInProgressNet
171000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4236000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4679000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
755000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
798000
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
6689000
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
5929000
CY2020Q2 us-gaap Assets
Assets
14906000
CY2019Q4 us-gaap Assets
Assets
9129000
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7774000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6348000
CY2020Q2 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
416000
CY2019Q4 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
842000
CY2020Q2 nwbo Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
4044000
CY2019Q4 nwbo Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
568000
CY2020Q2 nwbo Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
631000
CY2019Q4 nwbo Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
0
CY2020Q2 us-gaap Notes Payable Current
NotesPayableCurrent
8204000
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5501000
CY2020Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0
CY2019Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
66000
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
7524000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
7261000
CY2020Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
59666000
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
20213000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
311000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
395000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
88570000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
41194000
CY2020Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
3173000
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
6588000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4480000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4914000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7653000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11502000
CY2020Q2 us-gaap Liabilities
Liabilities
96223000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9129000
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
581000
CY2019Q4 us-gaap Liabilities
Liabilities
52696000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
722200000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
614300000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
722000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
614000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
811526000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
794900000
CY2020Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
31000
CY2019Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
10000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-895133000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-839907000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1599000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
836000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-81317000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-43567000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14906000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
572000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
920000
CY2020Q2 us-gaap Revenues
Revenues
2000
CY2019Q2 us-gaap Revenues
Revenues
581000
us-gaap Revenues
Revenues
572000
us-gaap Revenues
Revenues
920000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3120000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3291000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6877000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6295000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3330000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3013000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7501000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6575000
CY2020Q2 us-gaap Legal Fees
LegalFees
988000
CY2019Q2 us-gaap Legal Fees
LegalFees
914000
us-gaap Legal Fees
LegalFees
1363000
us-gaap Legal Fees
LegalFees
2453000
CY2020Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7438000
CY2019Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7218000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15741000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15323000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7436000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6637000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15169000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14403000
CY2020Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-49128000
CY2019Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
7201000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-36201000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4820000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-551000
CY2019Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
784000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1266000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1059000
CY2019Q2 us-gaap Interest Expense
InterestExpense
787000
us-gaap Interest Expense
InterestExpense
1684000
us-gaap Interest Expense
InterestExpense
1543000
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
222000
CY2019Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-342000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-906000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
43000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-50516000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6856000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-40057000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6324000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-57952000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
219000
us-gaap Net Income Loss
NetIncomeLoss
-55226000
us-gaap Net Income Loss
NetIncomeLoss
-20727000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
278000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-75000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-763000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-131000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58230000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
294000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54463000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20596000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
697555
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
550214
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
668972
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
539732
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
697555
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
597375
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
668972
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
539732
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-34992000
CY2020Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2903000
CY2020Q2 nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
2249000
CY2020Q2 nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
3997000
CY2020Q2 nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
2721000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-57952000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-278000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-81317000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-58496000
CY2019Q2 nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
1531000
CY2019Q2 nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
1250000
CY2019Q2 nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
1976000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
438000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
219000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
75000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-53007000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-43567000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
400000
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4948000
nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
4648000
nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
3997000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
2721000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
399000
us-gaap Net Income Loss
NetIncomeLoss
-55226000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
763000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-81317000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-47159000
nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
2219000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
1759000
nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
4977000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
991000
us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
4802000
us-gaap Net Income Loss
NetIncomeLoss
-20727000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
131000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-53007000
us-gaap Net Income Loss
NetIncomeLoss
-55226000
us-gaap Net Income Loss
NetIncomeLoss
-20727000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8000
nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
1073000
nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
663000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-36201000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4820000
nwbo Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
1266000
nwbo Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
4000
nwbo Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
163000
nwbo Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
222000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
399000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
991000
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
39118000
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
6708000
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-500000
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
664000
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
3000
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
44000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2075000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-742000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-426000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-4040000
nwbo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
94000
nwbo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
80000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13868000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19429000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1306000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
225000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1306000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-225000
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
11567000
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3997000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2219000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3557000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
6500000
nwbo Proceeds From Issuance Of Convertible Notes Payable
ProceedsFromIssuanceOfConvertibleNotesPayable
2189000
nwbo Proceeds From Issuance Of Convertible Notes Payable
ProceedsFromIssuanceOfConvertibleNotesPayable
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
315000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1363000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
420000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
64000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
329000
nwbo Repayment Of Convertible Notes Payable To Related Party
RepaymentOfConvertibleNotesPayableToRelatedParty
0
nwbo Repayment Of Convertible Notes Payable To Related Party
RepaymentOfConvertibleNotesPayableToRelatedParty
4002000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20198000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3968000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
559000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
138000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5583000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15548000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
372000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22224000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5955000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6676000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
2721000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
1759000
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
3558000
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
3994000
nwbo Offering Cost Related To Warrant Liability
OfferingCostRelatedToWarrantLiability
3842000
nwbo Offering Cost Related To Warrant Liability
OfferingCostRelatedToWarrantLiability
0
nwbo Warrants Issued Associated With Convertible Notes Payable
WarrantsIssuedAssociatedWithConvertibleNotesPayable
153000
nwbo Warrants Issued Associated With Convertible Notes Payable
WarrantsIssuedAssociatedWithConvertibleNotesPayable
0
nwbo Warrant Modification In Connection With Debt Amendment
WarrantModificationInConnectionWithDebtAmendment
51000
nwbo Warrant Modification In Connection With Debt Amendment
WarrantModificationInConnectionWithDebtAmendment
0
nwbo Conversion Of Outstanding Accounts Payables To Note Payable And Contingent Payable
ConversionOfOutstandingAccountsPayablesToNotePayableAndContingentPayable
0
nwbo Conversion Of Outstanding Accounts Payables To Note Payable And Contingent Payable
ConversionOfOutstandingAccountsPayablesToNotePayableAndContingentPayable
8560000
nwbo Issuance Of Common Shares In With Connection Settlement Agreement
IssuanceOfCommonSharesInWithConnectionSettlementAgreement
0
nwbo Issuance Of Common Shares In With Connection Settlement Agreement
IssuanceOfCommonSharesInWithConnectionSettlementAgreement
12000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payment arrangements, estimating the fair value of financial instruments recorded as derivative liabilities, useful lives of depreciable assets and whether impairment charges may apply.</p>
CY2020Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
59666000
CY2020Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
2115000
CY2020Q2 nwbo Contingent Payable Derivative Liability
ContingentPayableDerivativeLiability
7524000
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2020Q2 nwbo Share Based Compensation Arrangement By Share Based Payment Award Number Of Stock Options Agreed Not To Be Exercised By Holder
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfStockOptionsAgreedNotToBeExercisedByHolder
39200000
CY2020Q2 nwbo Share Based Compensation Arrangement By Share Based Payment Award Period During Which Stock Options Agreed Not To Be Exercised By Holder
ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodDuringWhichStockOptionsAgreedNotToBeExercisedByHolder
P6M
CY2020Q2 nwbo Share Based Compensation Arrangement By Share Based Payment Award Stock Option Extended Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionExtendedContractualTerm
P6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
78000
CY2020Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
69305000
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
20213000
CY2019Q4 nwbo Contingent Payable Derivative Liability
ContingentPayableDerivativeLiability
7261000
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
27474000
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1000000.0
us-gaap Share Based Compensation
ShareBasedCompensation
200000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
104659
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.24
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.22
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
102159
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11026000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
100056
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
10782000
nwbo Share Based Compensation Arrangement By Share Based Payment Award Number Of Stock Options Agreed Not To Be Exercised By Holder
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfStockOptionsAgreedNotToBeExercisedByHolder
39200000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
438000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
399000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
991000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-57952000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
12723000
CY2020Q2 us-gaap Interest Expense Other
InterestExpenseOther
5000
us-gaap Interest Expense Other
InterestExpenseOther
8000
us-gaap Interest Expense Other
InterestExpenseOther
1000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1059000
CY2019Q2 us-gaap Interest Expense
InterestExpense
787000
us-gaap Interest Expense
InterestExpense
1684000
us-gaap Interest Expense
InterestExpense
1543000
CY2020Q2 nwbo Constructions In Progress Net
ConstructionsInProgressNet
1541000
CY2019Q4 nwbo Constructions In Progress Net
ConstructionsInProgressNet
171000
CY2020Q2 us-gaap Depreciation
Depreciation
2000
CY2019Q2 us-gaap Depreciation
Depreciation
6000
us-gaap Depreciation
Depreciation
16000
us-gaap Depreciation
Depreciation
8000
CY2020Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
15457000
CY2020Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1520000
CY2020Q2 nwbo Fair Value Of Embedded Conversion Option
FairValueOfEmbeddedConversionOption
2115000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
16052000
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
13411000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
688000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
219000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-55226000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20727000
CY2020Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0
CY2019Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
125000
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-57952000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
344000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-55226000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-20727000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
697555
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
550214
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
668972
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
539732
CY2020Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2019Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
8631
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
697555
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
597375
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
668972
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
539732
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
454626000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
470521000
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
335661
CY2020Q2 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.25
nwbo Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
P1Y9M25D
CY2020Q2 nwbo Class Of Warrant Or Right Percentage Of Warrants Issued On Conversion
ClassOfWarrantOrRightPercentageOfWarrantsIssuedOnConversion
0.175
CY2020Q2 nwbo Class Of Warrant Or Right Suspended
ClassOfWarrantOrRightSuspended
81000000
CY2020Q2 nwbo Class Of Warrant Or Right Agreed To Be Suspended
ClassOfWarrantOrRightAgreedToBeSuspended
14200000
CY2020Q2 us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
7000
CY2019Q2 us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
137000
us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
11000
us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
328000
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
63000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
122000
CY2020Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
70000
CY2019Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
137000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
133000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
328000
CY2020Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8500000
CY2020Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P2Y
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
nwbo Fair Value Issuance Of New Warrants
FairValueIssuanceOfNewWarrants
1000000.0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2020Q2 nwbo Class Of Warrant Or Right Agreed To Be Suspended
ClassOfWarrantOrRightAgreedToBeSuspended
14600000
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
359473
CY2019Q4 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.27
CY2019 nwbo Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
P1Y5M1D
nwbo Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
55235
nwbo Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
0.23
nwbo Number Of Warrants Warrants Exercised For Cash
NumberOfWarrantsWarrantsExercisedForCash
15596
nwbo Weighted Average Exercise Price Exercised For Cash
WeightedAverageExercisePriceExercisedForCash
0.25
nwbo Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
63451
nwbo Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
0.0031
CY2020Q2 nwbo Class Of Warrant Or Right Agreed To Be Suspended And Unexercisable
ClassOfWarrantOrRightAgreedToBeSuspendedAndUnexercisable
90000000
CY2020Q2 nwbo Class Of Warrant Or Right Whose Exercise Period Is Extended
ClassOfWarrantOrRightWhoseExercisePeriodIsExtended
29000000
CY2020Q2 nwbo Class Of Warrant Or Right Whose Exercise Period Is Extended
ClassOfWarrantOrRightWhoseExercisePeriodIsExtended
29000000
CY2020Q2 nwbo Class Of Warrant Or Right Suspended
ClassOfWarrantOrRightSuspended
166500000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4000000.0
nwbo Stock Issued During Period Shares Warrant Exercises
StockIssuedDuringPeriodSharesWarrantExercises
15700000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4200000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4800000
CY2020Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P20Y
us-gaap Operating Lease Cost
OperatingLeaseCost
464000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
22000
us-gaap Variable Lease Cost
VariableLeaseCost
56000
us-gaap Lease Cost
LeaseCost
542000
us-gaap Operating Lease Payments
OperatingLeasePayments
499000
us-gaap Operating Lease Cost
OperatingLeaseCost
389000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
108000
us-gaap Variable Lease Cost
VariableLeaseCost
4000
us-gaap Lease Cost
LeaseCost
501000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
475000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
700000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
616000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
616000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
616000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
8610000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11633000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6842000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4791000

Files In Submission

Name View Source Status
0001104659-20-092797-index-headers.html Edgar Link pending
0001104659-20-092797-index.html Edgar Link pending
0001104659-20-092797.txt Edgar Link pending
0001104659-20-092797-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nwbo-20200630.xsd Edgar Link pending
nwbo-20200630x10q.htm Edgar Link pending
nwbo-20200630x10q_htm.xml Edgar Link completed
nwbo-20200630xex31d1.htm Edgar Link pending
nwbo-20200630xex32d1.htm Edgar Link pending
nwbo-20200630_cal.xml Edgar Link unprocessable
nwbo-20200630_def.xml Edgar Link unprocessable
nwbo-20200630_lab.xml Edgar Link unprocessable
nwbo-20200630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending